Political Storm Clouds Gather Over BioNTech’s Vaccine Business

A bombshell report from the Washington Post triggered a dramatic selloff in BioNTech shares this week, wiping out gains from positive oncology developments and casting a shadow over the company’s core vaccine operations. The selloff was sparked by revelations that health officials within the Trump administration are preparing to link COVID-19 vaccines to child fatalities.

According to the report, government officials intend to present findings connecting COVID-19 vaccines to 25 unconfirmed child fatalities to a CDC advisory committee as early as next week. The purported evidence is said to be based on unverified reports from the Vaccine Adverse Event Reporting System—a move that has reportedly alarmed veteran scientists within the medical community.

The market’s reaction was severe. BioNTech’s stock plummeted more than 7% on... Read more...